WSJ: FDA Staff Recommends Updated Warning For Asmanex

[Guest guest]

You need a subscription to see the whole article, but here is a quote: " said it

identified six reports of developmental delay in children that were not related

to birth defects, including two cases of autism in one family. "

JUNE 19, 2009, 10:18 A.M. ET FDA Staff Recommends Updated Warning For Asmanex >

SGP

http://online.wsj.com/article/BT-CO-20090619-707056.html

WASHINGTON (Dow )--U.S. Food and Drug Administration staff are recommending

an updated warning label for Asmanex, a Schering-Plough Corp. (SGP) asthma drug.

Separately, FDA staff recommended that Abbott Laboratories' (ABT) anti-seizure

drug Depakote be studied further to see if it causes developmental delays in

children.